Insurers and PBMs Limit Access to Safer Opioid Alternatives

Opioid abuse and addiction in America continues to ravish communities, families, and individuals across the nation. With an annual price tag exceeding $500 billion in health and social costs, solutions are needed to combat this growing problem before more damage is done.
Thankfully, the biopharmaceutical industry is hard at work developing novel and safer, next-generation therapies to treat both pain and addiction, but one challenge in particular continues to stand in the way: getting pharm